Results 351 to 360 of about 18,950,887 (401)
Some of the next articles are maybe not open access.

Geriatric drug evaluation: where are we now and where should we be in the future?

Archives of Internal Medicine, 2011
The older population is currently the fastest growing age group in the United States, and this trend is expected to continue for several decades. Older individuals, in general, have a higher disease burden compared with younger adults and are the major ...
S. Cho   +5 more
semanticscholar   +1 more source

Drug Usage Evaluation [PDF]

open access: possibleJournal of Pharmacy Practice, 1994
Drug usage evaluation (DUE) is a component of the Joint Commission on Accreditation of Healthcare Organizations guidelines for hospitals. If DUE is viewed with a positive focus rather than as simply a mandatory function, it can readily be exploited to benefit the institution.
openaire   +1 more source

Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers.

Nanoscale, 2017
The oral pathway is considered as the most common method for drug administration, although many drugs, especially the highly pH- and/or enzymatic biodegradable peptide drugs, are very difficult to formulate and achieve a good intestinal absorption ...
J. Florek, R. Caillard, F. Kleitz
semanticscholar   +1 more source

Evaluation of drug response

1986
Many of the rheumatic diseases exhibit a number of different clinical signs and symptoms. These are frequently related to multiple anatomical sites and in addition, there may be abnormalities in laboratory tests, on radiographic examination and in other specialized investigations.
R. Madhok, H. A. Capell
openaire   +2 more sources

Toxicological Evaluation of Drugs

1987
All drugs have the potential to produce toxicity. The degree to which such toxicity occurs in a compound as balanced against its therapeutic activity is termed the therapeutic index. Toxicity should be clearly dissociable from efficacy. The goal of toxicity testing is therefore to determine the adverse effects of drugs in well- defined biological ...
Joy Cavagnaro, Richard M. Lewis
openaire   +2 more sources

Drug evaluation studies in neonates: how to overcome the current limitations

Expert Review of Clinical Pharmacology, 2018
K. Allegaert   +2 more
semanticscholar   +1 more source

Drug Evaluation Data

Drug Intelligence & Clinical Pharmacy, 1971
Robert J. Allen   +8 more
openaire   +2 more sources

Clinical Evaluation of Drugs

Annual Review of Medicine, 1958
and L Lasagna, P Meier
openaire   +3 more sources

Home - About - Disclaimer - Privacy